New acyclic receptors containing pyridazine units. The influence of π-stacking on the selective transport of lipophilic phenethylamines

Tetrahedron

Volumn 61, Issue 50, 2005, Pages 11965-11975

  Campayo, Lucrecia ^a   Calzado, Fabián ^a   Cano, M Carmen ^a   Yunta, María J R ^a   Pardo, Mercedes ^a   Navarro, Pilar ^b   Jimeno, M Luisa ^b   Gómez Contreras, Fernando ^a   Sanz, Ana M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

Lipophilic phenethylamines carriers; Pyridazine receptors

Indexed keywords

AROMATIC COMPOUND; BENZENE; CALCIUM ION; DOPAMINE; HOMOVERATRYLAMINE; METAL ION; PHENETHYLAMINE DERIVATIVE; POTASSIUM ION; PYRIDAZINE DERIVATIVE; PYRIDAZINONE DERIVATIVE; PYRIDINE; SODIUM ION;

ARTICLE; CHEMICAL STRUCTURE; HYDROPHILICITY; LIPOPHILICITY; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

EID: 27744536066     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2005.09.069     Document Type: Article

References (48)

1. B.B. Hoffman, and R.J. Lefkowitz J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Ruddon Goodman and Gilman's the pharmacological basis of therapeutics 1996 McGraw-Hill New York Chapters 10, 22 and 24
2. S.B. Ligett Pharmacology 61 2000 167 173
3. M.G. Bock, and M.A. Patane Ann. Rep. Med. Chem. 35 2000 221 230
4. A. Sidhu, M. Laurelle, and P. Vernier Dopamine receptors and transporters Neurological disease and therapy series Vol. 56 2003 Marcel Dekker New York
5. C.D. Klaassen, and C.P. O'Brien J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Ruddon Goodman and Gilman's the pharmacological basis of therapeutics 1996 McGraw-Hill New York Chapters 4 and 24
6. Psychotropic agents handbook R. Remick A. Burgmann D. Thompson P. Schieldrop 2003 IGR Publications (Canada)
7. N.L. Keitner, and D.G. Folks Psychotropic drugs 4th ed. 2005 Mosby (Elsevier)
8. O.V. Mortensen, and S.G. Amara Eur. J. Pharmacol. 479 2003 159 170
9. E. O'Shea, B. Esteban, J. Camarero, and A.R. Green Neuropharmacology 40 2001 65 74
10. R. Simantov Life Sci. 74 2004 803 814
11. J.C. Cole, and H.R. Sumnall Pharmacol. Ther. 98 2003 35 58
12. L.S. Seiden, and M.S. Cleven K. Asghare E. de Souza Methamphetamine and related drugs: toxicity and resulting behavioural changes in response to pharmacological probes Pharmacology and toxicology of amphetamine and related designer drugs. National institute on drug abuse research monograph 94 1989 US government printing office Washington, DC 146 160
13. J.P. Behr, J.-M. Lehn, and P. Vierling Helv. Chim. Acta 65 1982 1853 1867
14. E. Kimura, A. Watanabe, and M. Kodama J. Am. Chem. Soc. 105 1983 2063 2066
15. A. Kimura, H. Fujioka, and M. Kodama J. Chem. Soc., Chem. Commun. 1986 1158 1159
16. H. Hayakawa, K. Kido, and K. Kanematsu J. Chem. Soc., Perkin Trans. 1 1988 511 519
17. L. Campayo, J.M. Bueno, C. Ochoa, P. Navarro, J. Jiménez-Barbero, G. Pèpe, and A. Samat J. Org. Chem. 62 1997 2684 2693
18. M.I. Rodriguez-Franco, P. San Lorenzo, A. Martinez, and P. Navarro Tetrahedron 55 1999 2763 2772
19. L. Lamarque, C. Miranda, P. Navarro, F. Escartí, E. García-España, J. Latorre, and J.A. Ramirez J. Chem. Soc., Chem. Commun. 2000 1337 1338
20. L. Lamarque, P. Navarro, C. Miranda, V.J. Arán, C. Ochoa, F. Escartí, E. García-España, J. Latorre, S.V. Luis, and J.F. Miravet J. Am. Chem. Soc. 123 2001 10560 10570
21. M. Herm, and T. Schrader Chem. Eur. J. 6 2000 47 53
22. M. Herm, O. Molt, and T. Schrader Chem. Eur. J. 8 2002 1485 1499
23. O. Molt, D. Rübeling, and T. Schrader J. Am. Chem. Soc. 125 2003 12086 12087
24. B. Escuder, A.E. Rowan, M.C. Feiters, and R.J.M. Nolte Tetrahedron 60 2004 291 300
25. J.P. Behr, J.M. Lehn, and P. Vierling J. Chem. Soc., Chem. Commun. 1976 621 623
26. W. Bussmann, J.M. Lehn, U. Oesch, P. Plumeré, and W. Simon Helv. Chim. Acta 64 1981 657 661
27. A. Domènech, E. García-España, P. Navarro, and F. Reviriego Talanta 51 2000 625 636
28. F. Reviriego, P. Navarro, A. Domènech, and E. García- España J. Chem. Soc., Perkin Trans. 2 2002 1634 1638
29. F. Reviriego, P. Navarro, A. Domènech, and E. García- España J. Supramol. Chem. 2 2002 115 122
30. A.M. Sanz, P. Navarro, F. Gómez-Contreras, M. Pardo, G. Pèpe, and A. Samat Can. J. Chem. 76 1998 1174 1179
31. D.E. Nichols Pharmacol. Ther. 101 2004 131 181 and references cited herein
32. L. Campayo, M. Pardo, A. Cotillas, O. Jauregui, M.J.R. Yunta, M.C. Cano, F. Gómez-Contreras, P. Navarro, and A.M. Sanz Tetrahedron 60 2004 979 986
33. E.A. Meyer, R.K. Castellano, and F. Diederich Angew. Chem., Int. Ed. 42 2003 1210 1250, and references cited therein
34. C. Janiak J. Chem. Soc., Dalton Trans. 2000 3885 3896
35. C.H. Hunter, K.R. Lawson, J. Perkins, and C.J. Urch J. Chem. Soc., Perkin Trans. 2 2001 651 669
36. P. Navarro, E. Pueyo, M.I. Rodriguez-Franco, and A. Samat Tetrahedron 46 1990 2917 2926
37. M. Fierros, M.I. Rodriguez-Franco, P. Navarro, and S. Conde Bioorg. Med. Chem. Lett. 4 1994 2523 2526
38. M.I. Rodriguez-Franco, M. Fierros, A. Martinez, P. Navarro, and S. Conde Bioorg. Med. Chem. 5 1997 363 367
39. P. Hobza, M. Kabelac, J. Sponer, P. Mejzlik, and J. Vondrasek J. Comput. Chem. 18 1997 1136 1150
40. X.X. Zhang, J.S. Bradshaw, and R.M. Izatt Chem. Rev. 97 1997 3313 3361
41. C.A. Hunter, and J.K.M. Sanders J. Am. Chem. Soc. 112 1990 5525 5534
42. K. Eichenberger, A. Staeheling, and J. Druey Helv. Chim. Acta 37 1954 837 840
43. W.D. Cornell, P. Cieplak, C. Bayly, I.R. Gould, K.M. Merz, D.M. Ferguson, D.C. Spellmeyer, T. Fox, J.W. Caldwell, and P.A. Kollman J. Am. Chem. Soc. 117 1995 5179 5197
44. Hyperchem 6.0, Hypercube Inc.
45. R. Jimenez, A.M. Sanz, F. Gomez-Contreras, M.C. Cano, M.J.R. Yunta, M. Pardo, and L. Campayo Heterocycles 63 2004 1299 1310
46. C. Miranda, F. Escartí, L. Lamarque, M.J.R. Yunta, P. Navarro, E. Garcia-España, and M.L. Jimeno J. Am. Chem. Soc. 126 2004 823 833
47. J. Wang, and P.A. Kollman J. Am. Chem. Soc. 120 1998 11106 11114
48. J.J. Urban, C.W. Cronin, R.R. Roberts, and G.R. Famini J. Am. Chem. Soc. 119 1997 12292 12299